Form 4: cbdMD, Inc. CEO and CFO Reports Transaction in Beneficial Ownership

Thomas Ronan Kennedy, CEO and CFO of cbdMD, Inc., reports a transaction involving preferred stock and adjustments to common stock holdings through a trust.

Summary

• Thomas Ronan Kennedy, the CEO and CFO of cbdMD, Inc. (YCBD), filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The reported transaction occurred on September 26, 2024.
• Kennedy acquired 1,000 shares of 8% Series A Cumulative Convertible Preferred Stock at $270.
• He also indirectly owns 41,765 shares of common stock through the CRED Trust, where he serves as trustee and has voting and dispositive control.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions without expressing any positive or negative outlook.

Future Outlook

The document does not contain specific forward-looking statements, but it outlines the conditions under which the preferred stock can be converted or redeemed, which could impact the company's capital structure.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into the transactions of company executives. It allows investors to monitor the actions of key personnel and their potential impact on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.
• The potential conversion or redemption of preferred stock could affect the value and dilution of common stock.

Key Dates

Keywords

Form 4, Beneficial Ownership, SEC Filing, cbdMD, YCBD, Preferred Stock, Common Stock, Insider Trading, Kennedy, CRED Trust